Caspase-2 is a mediator of apoptotic signaling in response to gemtuzumab ozogamicin in acute myeloid leukemia.


Journal

Cell death discovery
ISSN: 2058-7716
Titre abrégé: Cell Death Discov
Pays: United States
ID NLM: 101665035

Informations de publication

Date de publication:
11 Jun 2022
Historique:
received: 04 02 2022
accepted: 26 05 2022
revised: 02 05 2022
entrez: 11 6 2022
pubmed: 12 6 2022
medline: 12 6 2022
Statut: epublish

Résumé

The antibody conjugate gemtuzumab ozogamicin (GO; Mylotarg

Identifiants

pubmed: 35690610
doi: 10.1038/s41420-022-01071-9
pii: 10.1038/s41420-022-01071-9
pmc: PMC9188552
doi:

Types de publication

Journal Article

Langues

eng

Pagination

284

Subventions

Organisme : Cancerföreningen i Stockholm (Cancer Society in Stockholm)
ID : #151122
Organisme : Cancerföreningen i Stockholm (Cancer Society in Stockholm)
ID : #171123
Organisme : Cancerföreningen i Stockholm (Cancer Society in Stockholm)
ID : #201202
Organisme : Cancerföreningen i Stockholm (Cancer Society in Stockholm)
ID : #191293
Organisme : Cancerföreningen i Stockholm (Cancer Society in Stockholm)
ID : #181301
Organisme : Cancerfonden (Swedish Cancer Society)
ID : CAN 2016/649
Organisme : Cancerfonden (Swedish Cancer Society)
ID : CAN 2019/221
Organisme : Cancerfonden (Swedish Cancer Society)
ID : CAN 2015/401
Organisme : Cancerfonden (Swedish Cancer Society)
ID : CAN 2018/597
Organisme : Cancerfonden (Swedish Cancer Society)
ID : CAN 2021/1469 Pj01 H
Organisme : Cancerfonden (Swedish Cancer Society)
ID : #190345
Organisme : Familjen Erling-Perssons Stiftelse (Erling-Persson Family Foundation)
ID : # 2-2792/2017
Organisme : Familjen Erling-Perssons Stiftelse (Erling-Persson Family Foundation)
ID : # 4-1989/2020
Organisme : Familjen Erling-Perssons Stiftelse (Erling-Persson Family Foundation)
ID : # 2-2792/2017
Organisme : Familjen Erling-Perssons Stiftelse (Erling-Persson Family Foundation)
ID : # 4-1989/2020
Organisme : Ministry of Health and Social Affairs | Socialstyrelsen (National Board of Health and Welfare)
ID : # 2-2088/2017
Organisme : Ministry of Health and Social Affairs | Socialstyrelsen (National Board of Health and Welfare)
ID : #2-2088/2017
Organisme : Stockholms Läns Landsting (Stockholm County Council)
ID : # 20180404

Informations de copyright

© 2022. The Author(s).

Références

Leukemia. 2017 Mar;31(3):728-731
pubmed: 27795559
PLoS Genet. 2009 Jan;5(1):e1000324
pubmed: 19119425
J Cell Biol. 2017 Jun 5;216(6):1795-1810
pubmed: 28432080
Blood. 1998 Nov 1;92(9):3090-7
pubmed: 9787143
Cancer. 2005 Oct 1;104(7):1442-52
pubmed: 16116598
J Cell Biol. 2002 Dec 9;159(5):739-45
pubmed: 12460989
Biochim Biophys Acta. 2013 Oct;1833(10):2279-92
pubmed: 23747563
J Cell Sci. 2017 Nov 15;130(22):3779-3787
pubmed: 29142064
Nat Cell Biol. 2002 Nov;4(11):842-9
pubmed: 12402042
Blood. 2003 Jun 1;101(11):4589-97
pubmed: 12576328
Mol Cell Oncol. 2017 Jul 5;4(5):e1348325
pubmed: 29057309
Blood. 2013 Jun 13;121(24):4854-60
pubmed: 23591789
Science. 2001 Apr 27;292(5517):727-30
pubmed: 11326099
J Adv Pract Oncol. 2019 Jan-Feb;10(1):68-82
pubmed: 31308990
Cell Death Differ. 2004 Nov;11(11):1234-41
pubmed: 15297885
DNA Repair (Amst). 2003 Apr 2;2(4):363-74
pubmed: 12606118
Expert Rev Clin Pharmacol. 2018 Aug;11(8):755-760
pubmed: 29770715
Cell. 2007 Apr 20;129(2):423-33
pubmed: 17448999
Cancer Biol Ther. 2009 Aug;8(16):1559-66
pubmed: 19502782
Cell Death Dis. 2016 Dec 1;7(12):e2497
pubmed: 27906185
J Biol Chem. 1997 Aug 22;272(34):21010-7
pubmed: 9261102
Mol Cell Biol. 2001 Jun;21(11):3684-91
pubmed: 11340162
Cell. 1998 Aug 21;94(4):481-90
pubmed: 9727491
J Clin Oncol. 2011 Feb 1;29(4):369-77
pubmed: 21172891
J Biol Chem. 2002 Aug 16;277(33):29803-9
pubmed: 12065594
Mol Cell. 2012 Sep 14;47(5):681-93
pubmed: 22854598
Exp Hematol. 2009 Jun;37(6):755-66
pubmed: 19463775
Radiat Res. 2003 Apr;159(4):502-10
pubmed: 12643795
Best Pract Res Clin Haematol. 2019 Jun;32(2):116-126
pubmed: 31203993
J Cell Biol. 1999 Mar 8;144(5):903-14
pubmed: 10085290
Cell Death Differ. 1999 Jul;6(7):644-51
pubmed: 10453075
Leukemia. 2017 Sep;31(9):1855-1868
pubmed: 28607471
Nature. 1977 Nov 24;270(5635):347-9
pubmed: 271272
Cell Death Dis. 2013 Dec 05;4:e942
pubmed: 24309929
Br J Haematol. 2022 Jan;196(2):316-328
pubmed: 34350585
Leukemia. 2005 Feb;19(2):176-82
pubmed: 15592433
J Biol Chem. 2002 Apr 26;277(17):15147-61
pubmed: 11823470
Blood. 2011 Sep 15;118(11):3096-106
pubmed: 21719597
J Biol Chem. 2002 Apr 19;277(16):13430-7
pubmed: 11832478
Cell. 2008 May 30;133(5):864-77
pubmed: 18510930
Cell. 2005 Aug 26;122(4):593-603
pubmed: 16122426
Mol Cell. 2009 Sep 24;35(6):830-40
pubmed: 19782032
Blood. 2010 Jan 14;115(2):198-205
pubmed: 19901261
Science. 2002 Aug 23;297(5585):1352-4
pubmed: 12193789
Mol Cell Biol. 2008 Jun;28(12):3943-51
pubmed: 18426910
Cell. 2005 Aug 26;122(4):579-91
pubmed: 16122425
Blood Rev. 2018 May;32(3):167-183
pubmed: 29157973
Mol Biol Cell. 2005 Aug;16(8):3821-31
pubmed: 15917298
Lancet. 2012 Apr 21;379(9825):1508-16
pubmed: 22482940
Science. 2004 May 7;304(5672):843-6
pubmed: 15073321
Blood. 2001 Mar 15;97(6):1835-44
pubmed: 11238127
J Clin Pharmacol. 2001 Nov;41(11):1206-14
pubmed: 11697753
Cell. 1998 Aug 21;94(4):491-501
pubmed: 9727492

Auteurs

Petra Hååg (P)

Department of Oncology-Pathology, Karolinska Institutet, SE-171 64, Solna, Sweden. Petra.Haag@ki.se.

Magnus Olsson (M)

Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden.

Jeremy Forsberg (J)

Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden.

Marita Lagergren Lindberg (ML)

Department of Oncology-Pathology, Karolinska Institutet, SE-171 64, Solna, Sweden.

Bo Stenerlöw (B)

Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-75185, Uppsala, Sweden.

Dali Zong (D)

Department of Oncology-Pathology, Karolinska Institutet, SE-171 64, Solna, Sweden.
Laboratory of Genome Integrity, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.

Lena Kanter (L)

Department of Oncology-Pathology, Karolinska Institutet, SE-171 64, Solna, Sweden.

Rolf Lewensohn (R)

Department of Oncology-Pathology, Karolinska Institutet, SE-171 64, Solna, Sweden.
Theme Cancer, Medical Unit head and neck, lung and skin tumors, Thoracic Oncoflogy Center, Karolinska University Hospital, SE-171 64, Solna, Sweden.

Kristina Viktorsson (K)

Department of Oncology-Pathology, Karolinska Institutet, SE-171 64, Solna, Sweden.

Boris Zhivotovsky (B)

Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Faculty of Medicine, Lomonosov Moscow State University, 191992, Moscow, Russia.

Leif Stenke (L)

Department of Oncology-Pathology, Karolinska Institutet, SE-171 64, Solna, Sweden.
Theme Cancer, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Department of Medicine Solna, Karolinska Institutet, SE-171 64, Solna, Sweden.

Classifications MeSH